Searched for
PHARMA INDUSTRY EXTENSION
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- Sudip Bandyopadhyay bets on pharma, metals and select cyclicals as geopolitical risks easeEasing West Asia tensions boost global markets, prompting investors to reassess opportunities. Market veteran Sudip Bandyopadhyay favors ph...
- Call to extend duty cuts on critical inputs soonIndia is set to decide on extending customs duty relief for critical raw material imports beyond June 30. An inter-ministerial panel will r...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Over 60% of pharma MSMEs yet to comply with updated manufacturing normsPharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...
- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equity benchmarks ended lower on Tuesday, snapping a three-session rally amid profit booking in financial, realty and consumer sto...
- Stocks in news: ITC, LIC, Sun Pharma, Maruti Suzuki, Fino Payments BankBenchmark indices experienced a negative close on Thursday, marked by volatile trade and profit booking. Analysts anticipate the Nifty to c...
- Sun Pharma explores funding mix for $12 billion Organon dealGlobal lenders are exploring various financing options for Sun Pharmaceutical Industries' proposed $12 billion acquisition of Organon & Co....
- Sun Pharma-Organon deal: How a $12-billion merger will reshape India's pharma landscapeSun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The ...
- Sun Pharma to acquire Organon for $11.75 billion in India’s biggest pharma dealSun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...
- GST 2.0 Inverted duty structure hurts FMCG, Pharma: Expert flags concernsIndian enterprises are navigating challenges posed by the Goods and Services Tax. The inverted duty scenario is particularly affecting FMCG...
- Lalitpur Pharma Park gets export push as UPSIDA, JNPA sign pactUttar Pradesh State Industrial Development Authority and Jawaharlal Nehru Port Authority have partnered. This agreement aims to make the La...
- Health Minister Nadda seeks 'workable solution' to Schedule M issueUnion Health Minister JP Nadda is working on a solution for the pharmaceutical industry. Drug regulator and department of pharmaceuticals a...
- Ministry in talks with states to give some drug cos more time for good manufacturing practices complianceThe Union Health Ministry is in talks with states about extending the deadline for pharmaceutical companies to meet new manufacturing quali...
- Health minister seeks legal view on final schedule M draft noticeThe health ministry has sought a legal opinion on extending the deadline for MSMEs to comply with revised Schedule M standards. The final d...
- Centre may decide on rollout of Schedule M by next weekThe government is set to decide on implementing the revised Schedule M for pharmaceutical products by next week. While pharma groups have r...
- Erring drug companies to face stricter action as rules to improve mfg standards come into effect todayDrugmakers in India may soon face stricter enforcement of quality standards. The revised Schedule M, which details manufacturing practices ...
- Govt classifies genomics & pharma as sunrise opportunitiesThe finance minister Nirmala Sitharaman in her budget speech said the genomics and pharmaceuticals will get supportive policies, light-touc...
- Pharma pops brand-extension pillThe strategy of brand extensions, one of the biggest branding tools in the FMCG industry, is now finding application in the Indian pharma s...
Load More
